SUSQUEHANNA INTERNATIONAL GROUP, LLP - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 31 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$145,000
-1.4%
71,300
-30.6%
0.00%
Q1 2022$147,000
-0.7%
102,745
+14.4%
0.00%
Q4 2021$148,000
-83.8%
89,800
-68.7%
0.00%
Q3 2021$916,000
-67.2%
287,115
-49.2%
0.00%
Q2 2021$2,792,000
+71.3%
565,255
+186.2%
0.00%
Q1 2021$1,630,000
+2918.5%
197,520
+266.3%
0.00%
Q1 2020$54,00053,9230.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 291,973$931,0000.13%
Virtu Financial LLC 43,729$139,0000.01%
Jump Financial, LLC 30,551$97,0000.01%
Hudson Bay Capital Management LP 150,404$480,0000.01%
Paloma Partners Management Co 67,406$215,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 68,100$217,0000.00%
Tower Research Capital LLC (TRC) 31,568$101,0000.00%
Stratos Wealth Partners, LTD. 15,543$50,0000.00%
OPPENHEIMER & CO INC 23,013$73,0000.00%
Cutler Group LLC / CA 3,931$12,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders